Health Care & Life Sciences » Pharmaceuticals | Proteostasis Therapeutics Inc.

Proteostasis Therapeutics Inc. | Ownership

Companies that own Proteostasis Therapeutics Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Wellington Management Co. LLP
5,043,780
13.74%
216,220
0%
06/30/2018
Jennison Associates LLC
3,663,710
9.98%
41,856
0.01%
06/30/2018
BlackRock Fund Advisors
1,687,619
4.59%
1,643,966
0%
06/30/2018
RTW Investments LP
1,077,408
2.94%
-27,532
0.17%
06/30/2018
The Vanguard Group, Inc.
1,038,594
2.83%
94,568
0%
06/30/2018
Hillhouse Capital Management Ltd. (Hong Kong)
865,923
2.36%
0
0.03%
06/30/2018
FIL Investment Advisors (UK) Ltd.
652,316
1.78%
0
0%
06/30/2018
Bailard, Inc.
582,400
1.59%
62,300
0.07%
06/30/2018
Rock Springs Capital Management LP
471,321
1.28%
-203,679
0.05%
06/30/2018
Northern Trust Investments, Inc.
269,451
0.73%
226,417
0%
06/30/2018

About Proteostasis Therapeutics

View Profile
Address
80 Guest Street
Boston Massachusetts 02135
United States
Employees -
Website http://www.proteostasis.com
Updated 07/08/2019
Proteostasis Therapeutics, Inc. engages in the research, development, and market of pharmaceutical products. Its medicines intend to treat cystic fibrosis, protein conformational and neurodegenerative diseases. The company was founded by William Balch, Jeffery W.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.